{"DataElement":{"publicId":"2276","version":"3","preferredName":"RTOG Adverse Event Grade","preferredDefinition":"a coded numeric grade that describes the severity of a late adverse event reported during a study follow-up period using RTOG/EORTC grading system criteria (permissible values 0 to 5).","longName":"RTOG_AE_GD","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2188895","version":"1","preferredName":"RTOG Adverse Event Description","preferredDefinition":"information related to a RTOG adverse event description or grade.","longName":"RTOG_AE_DESC","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2637259","version":"1","preferredName":"Radiation Therapy Oncology Group Adverse Event","preferredDefinition":"The Radiation Therapy Oncology Group (RTOG) is a multi-institutional cooperative organization, a national cancer study research group comprised of 250 of the major research institutions nationally and in Canada, funded by NCI, headquartered in Philadelphia with almost 30 years of experience in running clinical trials. More than 40 clinical trials that involve radiation therapy either alone or in conjunction with surgery and/or chemotherapeutic drugs are active at any one time within RTOG. The group is interested in quality of life issues and their effects on the cancer patient:Any unfavorable and unintended sign (including an abnormal laboratory finding), symptom, syndrome, or disease, temporally associated with the use of a medical product or procedure, regardless of whether or not it is considered related to the product or procedure (attribution of unrelated, unlikely, possible, probable, or definite). The concept refers to events that could be medical product related, dose related, route related, patient related, caused by an interaction with another therapy or procedure, or caused by opioid initiation or dose escalation. The term also is referred to as an adverse experience. The old term Side Effect is retired and should not be used.","longName":"C19778:C41331","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Radiation Therapy Oncology Group","conceptCode":"C19778","definition":"A multi-institutional cooperative organization, a national cancer study research group comprised of 250 of the major research institutions nationally and in Canada, funded by NCI, headquartered in Philadelphia with almost 30 years of experience in running clinical trials. More than 40 clinical trials that involve radiation therapy either alone or in conjunction with surgery and/or chemotherapeutic drugs are active at any one time within RTOG. The group is interested in quality of life issues and their effects on the cancer patient","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Adverse Event","conceptCode":"C41331","definition":"Any unfavorable or unintended disease, sign, or symptom (including an abnormal laboratory finding) that is temporally associated with the use of a medical treatment or procedure, and that may or may not be considered related to the medical treatment or procedure. Such events can be related to the intervention, dose, route of administration, patient, or caused by an interaction with another drug(s) or procedure(s).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"301F06D5-45B5-1737-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-05-10","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-05-10","modifiedBy":"ONEDATA","dateModified":"2007-05-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2177536","version":"1","preferredName":"Description ","preferredDefinition":"Description; a statement that represents something in words.","longName":"Description","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Description","conceptCode":"C25365","definition":"A written or verbal account, representation, statement, or explanation of something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE29A78C-51C1-3A05-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-10-29","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-29","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008517","version":"1","preferredName":"Adverse Events","preferredDefinition":"any unfavorable symptoms, signs, or disease temporally associated with the use of a medical\r\ntreatment or procedure that may or may not be considered related to the medical\r\ntreatment or procedure.","longName":"AE","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB51E03C-635E-5672-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-09-23","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-09-23","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":"Definition copied from CTC Manual.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E5B5A047-9200-370A-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-10-05","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-10-05","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2015791","version":"3","preferredName":"RTOG Adverse Event Grade","preferredDefinition":"a coded numeric indicator that describes the severity of a late adverse event reported during a study follow-up period using RTOG/EORTC grading system criteria (permissible values 0 to 5).","longName":"RTOG_AE_GD","context":"CTEP","contextVersion":"2.31","type":"Non-enumerated","dataType":"NUMBER","minLength":"1","maxLength":"1","minValue":"0","maxValue":"5","decimalPlace":"0","PermissibleValues":[],"ConceptualDomain":{"publicId":"2008517","version":"1","preferredName":"Adverse Events","preferredDefinition":"any unfavorable symptoms, signs, or disease temporally associated with the use of a medical\r\ntreatment or procedure that may or may not be considered related to the medical\r\ntreatment or procedure.","longName":"AE","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB51E03C-635E-5672-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-09-23","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-09-23","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":"Definition copied from CTC Manual.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2184299","version":"1","preferredName":"Grade","preferredDefinition":"Describes how closely a cancer resembles normal tissue of its same type, and the cancer's probable rate of growth","longName":"Grade","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Histologic Grade","conceptCode":"C18000","definition":"The degree of abnormality of cancer cells, a measure of differentiation, the extent to which cancer cells are similar in appearance and function to healthy cells of the same tissue type. The degree of differentiation often relates to the clinical behavior of the particular tumor. Based on the microscopic findings, tumor grade is commonly described by one of four degrees of severity. Histopathologic grade of a tumor may be used to plan treatment and estimate the future course, outcome, and overall prognosis of disease. Certain types of cancers, such as soft tissue sarcoma, primary brain tumors, lymphomas, and breast have special grading systems.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DB6C8AC6-1C87-3E75-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-05-27","endDate":null,"createdBy":"SBREXT","dateCreated":"2004-05-27","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BA432147-D9BC-2188-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-04-01","endDate":null,"createdBy":"PWEST","dateCreated":"2003-04-01","modifiedBy":"CAMPBELB","dateModified":"2005-02-24","changeDescription":"updated for ISO compliance","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008587","version":"2","longName":"Type of Disease","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811949","version":"1","longName":"Brain","context":"CTEP"},{"publicId":"10000607","version":"1","longName":"Sarcoma","context":"CTEP"},{"publicId":"2811831","version":"1","longName":"Breast","context":"CTEP"},{"publicId":"2811871","version":"1","longName":"Colorectal","context":"CTEP"},{"publicId":"2811835","version":"1","longName":"Melanoma","context":"CTEP"},{"publicId":"2811910","version":"1","longName":"Prostate","context":"CTEP"},{"publicId":"2811907","version":"1","longName":"Bladder","context":"CTEP"},{"publicId":"2811908","version":"1","longName":"Gynecologic","context":"CTEP"},{"publicId":"2811832","version":"1","longName":"Lung","context":"CTEP"},{"publicId":"2811950","version":"1","longName":"Multiple Myeloma","context":"CTEP"},{"publicId":"2811912","version":"1","longName":"Head and Neck","context":"CTEP"},{"publicId":"2811913","version":"1","longName":"Lymphoma","context":"CTEP"},{"publicId":"2812017","version":"1","longName":"Phase II Lung Cancer","context":"CTEP"}]},{"publicId":"2008589","version":"2","longName":"Type of Category","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811955","version":"1","longName":"Follow-up","context":"CTEP"},{"publicId":"2811951","version":"1","longName":"Adverse Events","context":"CTEP"},{"publicId":"2812446","version":"1","longName":"Clinical Data Update System","context":"CTEP"}]},{"publicId":"2008594","version":"2.31","longName":"Trial Type Usages (CDE Disease Committees)","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2812015","version":"1","longName":"Metastatic Brain","context":"CTEP"},{"publicId":"2812013","version":"1","longName":"Primary Brain New","context":"CTEP"},{"publicId":"2812014","version":"1","longName":"Primary Brain Recurr","context":"CTEP"},{"publicId":"2811914","version":"1","longName":"Adjuvant Breast","context":"CTEP"},{"publicId":"2811919","version":"1","longName":"Advanced Melanoma","context":"CTEP"},{"publicId":"2811927","version":"1","longName":"Local-Reg Melanoma","context":"CTEP"},{"publicId":"2811916","version":"1","longName":"Localized Prostate","context":"CTEP"},{"publicId":"2811920","version":"1","longName":"Non-local Prostate","context":"CTEP"},{"publicId":"10000311","version":"1","longName":"Met/Urothelial","context":"CTEP"},{"publicId":"10000462","version":"1","longName":"Muscle Invasive Blad","context":"CTEP"},{"publicId":"10000312","version":"1","longName":"Superficial Bladder","context":"CTEP"},{"publicId":"2811817","version":"1","longName":"Primary Cervical","context":"CTEP"},{"publicId":"2811818","version":"1","longName":"Primary Endometrial","context":"CTEP"},{"publicId":"2811819","version":"1","longName":"Primary Ovarian","context":"CTEP"},{"publicId":"2811938","version":"1","longName":"Recurrent Gyn","context":"CTEP"},{"publicId":"2811810","version":"1","longName":"NSCLC 2nd Line","context":"CTEP"},{"publicId":"10000001","version":"1","longName":"NSCLC Advanced","context":"CTEP"},{"publicId":"2811821","version":"1","longName":"SCLC 2nd Line","context":"CTEP"},{"publicId":"2811822","version":"1","longName":"SCLC Extensive","context":"CTEP"},{"publicId":"2811823","version":"1","longName":"SCLC Limited","context":"CTEP"},{"publicId":"2811931","version":"1","longName":"NSCLC Stage I-III","context":"CTEP"},{"publicId":"2811904","version":"1","longName":"Multiple Myeloma","context":"CTEP"},{"publicId":"2811905","version":"1","longName":"Primary Amyloidosis","context":"CTEP"},{"publicId":"2811906","version":"1","longName":"Waldenstrom Macrogl","context":"CTEP"},{"publicId":"2811884","version":"1","longName":"Adult STS New","context":"CTEP"},{"publicId":"2811885","version":"1","longName":"Adult STS Recurrent","context":"CTEP"},{"publicId":"10000027","version":"1","longName":"Bone Sarcoma New","context":"CTEP"},{"publicId":"10000028","version":"1","longName":"Bone Sarcoma Recur","context":"CTEP"},{"publicId":"2811886","version":"1","longName":"Ped STS New","context":"CTEP"},{"publicId":"2811889","version":"1","longName":"Ped STS Recurrent","context":"CTEP"},{"publicId":"10000369","version":"1","longName":"Curative Head/Neck","context":"CTEP"},{"publicId":"10000614","version":"1","longName":"Palliative Head/Neck","context":"CTEP"},{"publicId":"2811943","version":"1","longName":"Hodgkin's Lymphoma","context":"CTEP"},{"publicId":"2811944","version":"1","longName":"NonHodgkins Lymphoma","context":"CTEP"}]},{"publicId":"2008608","version":"1","longName":"Phase","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811891","version":"1","longName":"Phase II","context":"CTEP"}]},{"publicId":"2604617","version":"1","longName":"Submission and Reporting","context":"CTEP","ClassificationSchemeItems":[{"publicId":"10000130","version":"1","longName":"Clinical Data Update System","context":"CTEP"},{"publicId":"2812619","version":"1","longName":"Patient Treatment by Course","context":"CTEP"}]},{"publicId":"4057943","version":"1","longName":"Disease Site","context":"NRG","ClassificationSchemeItems":[{"publicId":"10000172","version":"1","longName":"GOG-0241","context":"NRG"},{"publicId":"4104913","version":"1","longName":"GOG-0241","context":"NRG"},{"publicId":"4104888","version":"1","longName":"GOG-0209","context":"NRG"},{"publicId":"10000593","version":"1","longName":"GOG-0212","context":"NRG"},{"publicId":"4104908","version":"1","longName":"GOG-0212","context":"NRG"},{"publicId":"10000594","version":"1","longName":"GOG-0212","context":"NRG"},{"publicId":"4104897","version":"1","longName":"GOG-0250","context":"NRG"},{"publicId":"4104910","version":"1","longName":"GOG-0218","context":"NRG"},{"publicId":"10000080","version":"1","longName":"GOG-0218","context":"NRG"},{"publicId":"10000079","version":"1","longName":"GOG-0218","context":"NRG"},{"publicId":"4104896","version":"1","longName":"GOG-0249","context":"NRG"},{"publicId":"4104879","version":"1","longName":"GOG-0219","context":"NRG"},{"publicId":"10000287","version":"1","longName":"GOG-0213","context":"NRG"},{"publicId":"4104909","version":"1","longName":"GOG-0213","context":"NRG"},{"publicId":"10000288","version":"1","longName":"GOG-0213","context":"NRG"},{"publicId":"4104883","version":"1","longName":"GOG-0240","context":"NRG"},{"publicId":"4104917","version":"1","longName":"GOG-0262","context":"NRG"},{"publicId":"10000174","version":"1","longName":"GOG-0262","context":"NRG"},{"publicId":"10000175","version":"1","longName":"GOG-0262","context":"NRG"},{"publicId":"4104885","version":"1","longName":"GOG-0263","context":"NRG"},{"publicId":"4104991","version":"1","longName":"GOG-0275","context":"NRG"},{"publicId":"4104900","version":"1","longName":"GOG-0277","context":"NRG"},{"publicId":"4104898","version":"1","longName":"GOG-0258","context":"NRG"},{"publicId":"4104899","version":"1","longName":"GOG-0261","context":"NRG"}]}],"AlternateNames":[{"name":"0002705","type":"HISTORICAL_CDE_ID","context":"CTEP"},{"name":"0064857","type":"HISTORICAL_CDE_ID","context":"CTEP"},{"name":"0002385","type":"HISTORICAL_CDE_ID","context":"CTEP"},{"name":"0062824","type":"HISTORICAL_CDE_ID","context":"CTEP"},{"name":"0061328","type":"HISTORICAL_CDE_ID","context":"CTEP"},{"name":"0002509","type":"HISTORICAL_CDE_ID","context":"CTEP"},{"name":"RTOG_AE_GD","type":"USED_BY","context":"NRG"}],"ReferenceDocuments":[{"name":"Late Adverse Event Grade","type":"Preferred Question Text","description":"Late Adverse Event Grade","url":null,"context":"CTEP"},{"name":"CRF Text","type":"Alternate Question Text","description":"Late Adverse Event Grade","url":null,"context":"CTEP"},{"name":"Source","type":"DATA_ELEMENT_SOURCE","description":"Data element and all values comply with Clinical Data Update System (CDUS) v3.0 Release 2","url":"http://ctep.cancer.gov/reporting/cdus.html","context":"CTEP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"BA4295F1-737B-29D1-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-04-01","endDate":null,"createdBy":"PWEST","dateCreated":"2003-04-01","modifiedBy":"FORMBUILDER","dateModified":"2014-07-29","changeDescription":"updated for ISO compliance; merged into 1 element common across diseases","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}